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In the development of transdermal and topical products it is important to understand how formulation
ingredients interact with the molecular components of the upper layer of the skin, the stratum corneum
(SC), and thereby influence its macroscopic barrier properties. The aim here was to investigate the effect
of two commonly used excipients, transcutol and dexpanthenol, on the molecular as well as the macro-
scopic properties of the skin membrane. Polarization transfer solid-state NMR methods were combined
with steady-state flux and impedance spectroscopy measurements to investigate how these common
excipients influence the molecular components of SC and its barrier function at strictly controlled hydra-
tion conditions in vitro with excised porcine skin. The NMR results provide completely new molecular
insight into how transcutol and dexpanthenol affect specific molecular segments of both SC lipids and
proteins. The presence of transcutol or dexpanthenol in the formulation at fixed water activity results
in increased effective skin permeability of the model drug metronidazole. Finally, impedance spec-
troscopy data show clear changes of the effective skin capacitance after treatment with transcutol or dex-
panthenol. Based on the complementary data, we are able to draw direct links between effects on the
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formulations containing transcutol or dexpanthenol.
 2016 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The outermost layer of skin is called the stratum corneum (SC)
and constitutes the main barrier towards both inward and outward
diffusional transport [1]. The barrier properties of SC are assured by
its organization of dead keratin-filled cells, corneocytes, embedded
in an extracellular matrix of lipid arranged in a multilamellar
structure [2–4]. Although SC normally experience low relative
humidity (RH), the exposure to very dry environments can lead
to defective skin conditions, such as dry skin with reduced barrier
function [5]. The continuous hydration of SC from the inside of the
body, driven by the water gradient between the water-rich tissue
and the surrounding environment, is consequently one crucial
parameter for maintaining healthy skin [6,7]. In many cases of
dry and defective skin, it is common to use topical formulations
containing excipients and/or active substances that have beneficial
effects on skin health. Considering this, the influence of hydration
on the SC is particularly relevant for the optimization of topical for-
mulations for treatment of skin diseases. Skin hydration is impor-
tant both in relation to the state of the skin disease, as well as to
the molecular organization of the skin lipid and protein compo-
nents, and the partitioning and diffusion of drugs and excipients
in the SC matrix. In many cases the degree of skin hydration is
altered by topical treatment with a formulation, and it is well
known that changes in skin hydration can lead to changes in skin
permeability [8–10]. In previous studies, we have demonstrated
that changes of a gradient in water activity across the skin can
be used as a switch to regulate the skin permeability to different
model drugs in a reversible manner [11]. This effect was later cor-
related to reversible structural and dynamical changes of the SC
lipid or protein components [12–14]. It was found that increased
SC hydration leads to mobilization of the non-aqueous SC compo-
nents, associated with increased solubility and lowered diffusional
resistance to external chemicals, for example, drugs or excipients
in a formulation [11–13,15].
A common treatment of skin disease is topical application of a
pharmaceutical product in which the active drug ingredient repre-
sents a minor fraction of the total formulation, while the excipients
comprise the major part. Usually the excipients include, for exam-
ple, solvents, penetration enhancers, and humectants, and all these
compounds can have large impact on the treatment and the pro-
gression of the skin disease [16]. Therefore the topical formulation
has to be optimized by considering how different excipients inter-
act within the formulation, as well as with the lipid and protein
components of the skin. In this analysis, it is important to consider
both the molecular and the macroscopic effects caused by the topi-
cal formulation in order to gain a fundamental understanding ofHO
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R chemical shifts (web: http://sdbshow the skin barrier is influenced. This evaluation should also con-
sider how the applied formulation influences the skin hydration. In
order to distinguish the effects of certain formulation components
from the overall effect of the formulation on skin hydration, it is
desirable to make the comparisons to reference samples of the skin
at the same water activity. All these important issues are consid-
ered in the present study, where we investigate how the excipient
molecules transcutol, TC, and dexpanthenol, DexP, (see Fig. 1)
influence the mobility of SC molecular components and the SC bar-
rier function at controlled hydration conditions.
The present experimental approach is based on previous studies
where the molecular effect of small polar molecules, such as urea
and glycerol, was linked to their effects on the skin barrier function
[17,18]. Similar to urea and glycerol, both TC and DexP are used in
commercial skincare products. Urea and glycerol are also naturally
present in skin as part of the so-called Natural Moisturizing Factor
(NMF), which comprise a mixture of small polar molecules, such as
free amino acids and their derivatives. The presence of NMF sub-
stances is considered crucial to maintain SC hydration in dry con-
ditions [19]. Further, the effect of urea and glycerol on diseased
skin has been emphasized in vivo, where formulations containing
these substances reduce dryness [20,21]. From recent in vitro stud-
ies it was shown that urea and glycerol increase the molecular
mobility of both SC lipids and proteins at moderate relative humid-
ity where the SC components are considerably more rigid in the
absence of these compounds, and it is notable that this effect could
not be attributed to increased SC water content [18]. Considering
that TC and DexP are small (i.e. low molecular weight) and polar
and therefore have similar physicochemical properties as urea,
glycerol, and other NMF substances, it is of basic relevance to
investigate how these excipient molecules influence the molecular
and macroscopic properties of the skin barrier in comparison to
these previously investigated substances.
From an application perspective, TC is a safe and well tolerated
solvent used in many cosmetic and pharmaceutical products for
skin where its ability to dissolve poorly soluble substances is a
clear benefit [22]. Likewise, DexP is found in many cosmetic prod-
ucts with the aim to increase the skin hydration and maintain skin
softness, possibly due to its hygroscopic properties [23]. It has also
been proposed that DexP can improve wound healing by activating
fibroblast proliferation and accelerating the regeneration of the
epidermal barrier [24,25]. However, a detailed understanding of
the molecular interactions of TC and DexP with the protein and
lipid molecular components of SC is lacking [22,26]. Also, the
mechanism of TC and DexP on skin hydration and skin permeabil-
ity is poorly understood. These aspects are addressed in the pre-
sent paper where polarization transfer solid-state NMR methodsH
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measurements to investigate how TC and DexP influence the
molecular components of SC and its barrier function at strictly con-
trolled hydration conditions. The experiments are performed
in vitro with excised porcine skin. For the steady-state flux exper-
iments the model drug metronidazole (Mz) is used (Fig. 1C), which
we have employed also in previous studies [11,17]. Mz is a relevant
model drug as it is commercially used as an antibacterial drug for
treatment of the skin disease rosacea. Based on the complementary
data from NMR, impedance spectroscopy and steady-state flux
measurements, we are able to draw direct links between effects
on the molecular properties and on the macroscopic barrier func-
tion of the skin barrier under treatment with formulations contain-
ing TC or DexP.2. Materials and methods
2.1. Materials
NaCl, KH2PO4, Na2HPO42H2O (all p.a. grade), MeOH (chroma-
solv grade), trypsin from bovine pancreas (T9201, P90% protein),
and metronidazole (Mz, M3761, analytical standard grade,
Mw = 171 g mol1, log P = 0.02) were purchased from Sigma
Aldrich. Transcutol (TC, Mw = 134 g mol1, log P = 0.42, ph. Eur.
grade) was purchased from BASF and dexpanthenol (DexP,
Mw = 205 g mol1, log P = 0.99, ph. Eur. grade) was obtained from
Gattefossé. Phosphate buffered saline (PBS) was prepared from
deionized water (130.9 mM NaCl, 5.1 mM Na2HPO42H2O, and
1.5 mM KH2PO4, pH = 7.4). All formulations containing Mz were
prepared in PBS with varying concentrations of TC or DexP, thus
ensuring that both the active and excipient molecules are
uncharged. The concentration of Mz was adjusted based on solubil-
ity data to obtain approximately the same thermodynamic activity
of Mz in all formulation.
2.2. Preparation of skin membranes and the stratum corneum (SC)
samples
Pig ears were obtained from a local abattoir and stored at
80 C until use. Skin from the inside of the outer ear was der-
matomed (TCM 3000 BL, Nouvag) to obtain skin strips with
0.5 mm thickness. Circular skin membranes with a diameter of
1.6 cm were punched out to fit the diffusion cells. SC samples to
be studied with NMR were prepared by placing dermatomed skin
strips for approximately 12 h on filter paper soaked in 0.2 wt%
trypsin in PBS. Next, sheets of SC were removed with forceps and
thoroughly washed in PBS. In this step, care was taken to remove
tissue not belonging to SC by rubbing the downside of the SC
sheets with cotton tipped applicators followed by rinsing in PBS.
In order to avoid complications due to biological variation SC
sheets were collected from several individual ears and cut in small
pieces and pooled in one batch from which all samples were
prepared.
2.3. Polarization transfer solid-state NMR (PT ssNMR) measurements
on SC
The influence of TC and DexP on the molecular dynamics in SC
lipid and protein components was investigated by means of solid-
state NMR. For this purpose, SC sheets were soaked in formulations
for 8 h at 32 C. The formulations contained either TC or DexP (5 or
30 wt%) in PBS solution. The SC sheets were then carefully wiped
with paper tissues to remove excess formulation and placed
directly into the NMR inserts. As a reference, SC sheets were pre-
pared in an identical manner in neat PBS solution with no addedTC or DexP. A comparison between the results from the reference
sample and previously obtained results on SC sheets prepared in
the same manner (i.e. soaked in PBS) [14] showed virtually identi-
cal spectra, thus demonstrating good reproducibility. In some
experiments, SC sheets were equilibrated at 32 C in a desiccator
at 93%RH (adjusted by 2.02 mol kg1 NaCl aqueous solution), cor-
responding to similar water activity as the formulation with
30 wt% TC or DexP.
NMR experiments were performed on a Bruker Avance-II 500
NMR spectrometer, equipped with a Bruker Efree 4 mmMAS probe
at 1H and 13C resonance frequencies of 500 and 125 MHz, respec-
tively. The magic-angle spinning (MAS) frequency was set to
5 kHz. The temperature was 32 C and calibrated by methanol
[27]. The CP (cross polarization) [28] and INEPT (insensitive nuclei
enhanced by polarization transfer) [29] for 1H–13C polarization
transfer are commonly used schemes to enhance 13C signal. By
comparing the signal intensities acquired with CP, INEPT and DP
(direct polarization), where the latter shows resonances from all
carbon segments in the sample and is used as a reference, site-
specific information about molecular mobility can be obtained.
We denote the DP-CP-INEPT set of experiments PT ssNMR (Polar-
ization Transfer solid-state NMR) [30,31] for brevity. 13C spectra
were acquired under 68 kHz two-pulse phase modulation (TPPM)
1H decoupling [32] using a spectral width of 250 ppm and an acqui-
sition time of 0.05 s. 1H and 13C hard pulses were applied at
x1H/C/2p = 80 kHz. Ramped CP was performed with the contact time
1 ms, the 13C nutation frequency 80 kHz and the 1H nutation fre-
quency linearly ramped from 72 to 88 kHz. The delays s = 1.8 ms
and s0 = 1.2 ms were used in INEPT. 2048 scans per experiment
were collected with 5 s recycle delay giving a total time of approx-
imately 8 h for all 3 experiments. The 13C spectra were externally
referenced to the methylene signal of solid a-glycine at 43.7 ppm.
The data were processed with line broadening of 10 Hz, zero-
filling from 1597 to 8192 time-domain points, Fourier transform,
automatic phase correction [33], and baseline correction in Matlab
using in-house code, partially derived from matNMR [34].
2.4. Adjustments of drug activity in the model formulations
We aim at formulations with different concentrations of the
excipients (i.e. TC or DexP) but constant Mz activity in order to
relate the observed differences in model drug flux across the skin
membrane to changes caused by the excipients. To accomplish this
we followed the procedure from previous studies [11,17]. In brief,
the solubility of Mz was determined in neat PBS solution and in
mixtures of TC or DexP in PBS solution. This was performed by
mixing 3 g of formulation with excess Mz and stirring the satu-
rated solution for 3 days in water-tight vials at 32 C. Three repli-
cates of each formulation were prepared. The saturated
suspensions were then filtered through 0.2 lm syringe filters
(Ø = 13 mm, PTFE membranes, VWR), discarding the first part of
the filtrate. Next, the saturated solutions were diluted appropri-
ately before analysis (20 ll filtrate to 50 mL PBS). The final step
was repeated one time for all replicate formulations (n = 6). The
results are summarized in Table S1. Statistical outliers of the Mz
solubility were excluded based on a two sided Grubbs’ test at
p = 0.05. The solubility limit of Mz equals the concentration corre-
sponding to maximum activity (Fig. S1). After determining the sol-
ubility in each formulation, the concentration of Mz was adjusted
to a determined concentration below the solubility limit to avoid
precipitation of Mz, which can occur when handling close to satu-
rated formulations. Here, the concentration of Mz in the solution of
neat PBS was chosen to match the concentration used in commer-
cial products that contains 0.75 wt% (7.5 mg mL1), which corre-
sponds to 60% of the saturation concentration of Mz in PBS
(Table S1). The factor of 0.6 was then consistently used to set the
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in all formulations. For clarity, the adjusted concentrations of Mz in
all formulations are compiled in Table S1.
2.5. Water activity in the model formulations
Water activity was measured for all formulations (n = 2) using a
NovaSina LabMaster-aw apparatus at 32 C. The instrument was
calibrated with saturated salt solutions (83.6 and 97.0%RH) and
milli-Q water (close to 100%RH) before measurements. The formu-
lations were allowed to reach thermal equilibrium and then a
stable value was recorded for a minimum period of 30 min. The
results are compiled in Fig. S2, showing that the water activity
decreases linearly with the molar concentration of the solute, irre-
spective of the type of solute (i.e. TC or DexP). The water activity in
the same donor formulations was again measured after the diffu-
sion experiments. A change in water activity would imply that
there is a significant change in composition of the donor formula-
tion over time during the experiment. The conclusion from these
control experiments is that the water activity remained approxi-
mately constant (less than 1.5% change) during the diffusion-cell
experiments.
2.6. Flow-through diffusion cell experiments
Diffusion experiments were performed with a flow-through cell
set-up, which enables automatic sampling from 15 diffusion cells
(Ø = 0.90 cm) [35,36]. The cells are kept in a heater block con-
nected to a circulating water bath (Techne TE-10A Thermoregula-
tor), ensuring a constant temperature of 32 C, and placed on top
of a magnetic stirrer (Multipoint 15 Magnetic Stirrer, Variomag)
with mixing of both the receptor and donor solutions at 200 rpm.
The receptor phase was degassed at reduced pressure for approxi-
mately 1 h before starting the experiment to minimize formation
of air bubbles under the membranes. The membranes were
hydrated by placing them in the diffusion cells with flowing recep-
tor solution for approximately 1 h before applying 2 mL of formu-
lation (this procedure was not executed for membranes included in
the impedance study, see below). The receptor solution was
pumped (Ismatec IPC-16) through the system with a flow rate of
1.5 mL h1. Directly after applying the formulations, the donor
compartments were sealed with parafilm to avoid evaporation of
water. Fractions of receptor solution were collected (Gilson FC
204 Fraction collector) in 2 h intervals during 24 h, starting from
the time when the donor formulation was applied.
The data from the diffusion experiments were analyzed from
curves of cumulative mass permeated per membrane area as a
function of time. Data are presented as the steady-state flux
(lg cm2 h1) across the skin membrane, which was determined
from the slope of the linear region of the curve that corresponds
to steady-state conditions. For this analysis, 5 data points between
16 and 24 h were used (see Fig. S3 for example of data). Statistical
outliers in the data of the steady-state fluxes were excluded based
on a two sided Grubbs’ test at p = 0.05. The choice of time intervals
was justified by the time required to reach steady-state flux, and
this time is influenced by the water activity in the donor formula-
tion [11]. To ensure steady-state conditions, we aim at constant
composition of the donor and receptor phases during the course
of the experiment. Therefore, the donor solution was applied in
excess (i.e. 2 mL). Further, the receptor solution was continuously
renewed by the flow-through set-up to assure low concentration
of Mz in the receptor phase. Control measurements showed no
major changes in the water activity in the donor solutions before
and after the experiments, thus implying that the composition of
the donor solutions remains virtually unchanged over the period
of the experiment. Moreover, the total amounts of Mz (n = 54),TC (n = 7) and DexP (n = 7) that reached the receptor phase by
the end of the experiment were determined. The amount of Mz
in the receptor solution was 0.31% of the total amount in the donor
solution, while the corresponding value for TC was determined to
0.45%. The measured concentration of DexP in the receptor solu-
tion by the end of the experiment was below the limit of detection
(100 lg g1), which implies slow diffusion of this substance from
the donor solution across the skin membrane. The amount of Mz,
TC or DexP that was dissolved in the skin membrane was not
investigated.
2.7. Analytical procedures
In the solubility study, the concentration of Mz was determined
by UV spectrophotometry (Cary 50, Varian Inc.). No signs of absor-
bance from TC or DexP were observed between 200 and 800 nm,
while the wavelength of maximum absorbance for Mz was deter-
mined to 319 nm and used for quantification. The concentration
of Mz was calculated from calibration curves of standard solutions
with known concentrations (1, 2.5 5.0, 7.5, 10.0, 15.0, and
20.0 lg g1).
The concentration of Mz in the receptor phase was analyzed by
reversed phase HPLC-UV. 20 ll of receptor solution was injected
using an automatic sample injector (Rainin Dynamax model
AI-1A) with a 10 ll injection loop. The mobile phase consisted of
filtered and degassed methanol:phosphate buffer (10 mM KH2PO4)
(20:80 v/v). The flow rate was set to 2.0 mL min1 (Varian 9012
solvent delivery system). A C18 column (pore size = 120 Å, particle
size = 5 lm, dimensions = 50  4.6 mm i.d.) was used in series with
an external guard holder equipped with C18 guard cartridges (pore
size = 120 Å, particle size = 5 lm, dimensions = 10  4.0 mm i.d.).
The retention time for Mz detection (Thermo Separation Products,
Spectra 100) was 1.9 min.
The concentration of TC and DexP in the receptor phase was
analyzed by gas chromatography mass spectrometry (GC/MS). An
Agilent 7000 GC triple quad MS (Agilent Technologies) operated
in MS scan mode (m/z 50–650) was used. 1 ll was injected into
the multimode inlet (50 C, 600 C min1 to 200 C). The injected
sample was separated on a 30 m  0.25 mm i.d. capillary column
coated with 0.25 lm stationary phase, BPX 50 (Scientific glass
Engineering, SGC part no. 054751) using temperature gradient pro-
gramming (50 C for 2 min followed by 20 C min1 to 250 C). The
carrier gas was helium at a flow of 1.2 mL min1. The transfer line
into the mass spectrometer was maintained at 280 C. The analytes
were detected by electron ionization (EI, 70 eV). Reference solu-
tions of TC (1, 5, 10, 50, and 100 lg mL1) were prepared in PBS
and linearity was demonstrated for this concentration range. The
TC concentration was determined from the response of the
10 lg mL1 reference solution using the external standard princi-
ple. Samples from experiments where the formulations contained
5 wt% TC were diluted 10 times with water prior to injection. In
the corresponding case where the formulations contained 30 wt%
TC, the samples were diluted 100 times. The retention time for
TC was 4.6 min and the run time was set to 12 min. The EI mass
spectrum was confirmed by comparison with corresponding spec-
tra from the NIST 11 MS library database. Two injections were car-
ried out for each sample solution. Reference solutions were
injected multiple times throughout the sequence. The concentra-
tion of DexP was below the detection limit for all receptor solution
samples investigated.
2.8. Impedance spectroscopy on skin membranes
Electrical impedance measurements were performed with a
Franz cell (Ø = 0.90 cm, V = 6 mL, PermeGear Inc.) equipped with
four electrodes connected to a potentiostat from Ivium
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working and counter electrodes, while Ag/AgCl/3M KCl electrodes
(World Precision Instruments) were used as sensing and reference
electrodes. The frequency range was set from 1 MHz to 0.5 Hz with
7 frequencies per decade, which resulted in a total measuring time
of less than 1 min. The amplitude of the applied voltage was set to
25 mV ensuring low current densities in the lower frequency
range. The water jacket was kept at 32 C by a circulating water
bath (Techne TE-10A Thermoregulator).
Initial impedance scans were measured on skin membranes
that had been hydrated for approximately 1–2 h by placing them
on filter paper soaked in PBS at room temperature. Next, the mem-
branes were placed in the flow-through diffusion cells for determi-
nation of the Mz steady-state flux as described above. After the
diffusion experiments, the membranes were taken from the flow-
through diffusion cells and placed on a filter paper soaked in PBS.
Finally, the membranes were sequentially mounted in the Franz
cell for the final impedance measurements. Both initial and final
measurements were conducted by placing the skin membrane on
top of the receptor chamber with the dermal side facing the recep-
tor solution, which consisted of degassed PBS. Then the donor
chamber was clamped on top of the receptor chamber and filled
with degassed PBS solution. For each set of experiment (i.e. initial
or final impedance measurements) the time difference between
the first and last measurement was less than 60 min. The impe-
dance experiments were designed with consideration of the natu-
ral variability in skin membrane impedance previously reported
[37–39]. Our experimental design circumvents this natural vari-
ability as it generates experimental data from the same membrane
before and after being in contact with the applied model drug
formulation.
For analysis of the skin impedance data we employed a model
circuit (Fig. S4B), consisting of a resistor (solution resistance, Rsol)
in series with a parallel arrangement of a resistor (skin membrane
resistance, R) and a constant-phase element (CPE). This circuit is
frequently used for analyzing skin impedance data [14,40–42].
The resistance values were obtained from the real part of the impe-
dance in the frequency regions where the imaginary part gives
minimum contribution to the total impedance. For Rsol, this region
corresponds to high frequencies in the range of 0.2–0.1 MHz. In
average, Rsol = 134 ± 4X (±SEM) including all measurements
(n = 60). The corresponding frequency region for the membrane
resistance R occurs at low frequencies close to direct current
(DC) where R = ZRe  Rsol. In this analysis, all data were normalized
with the skin membrane area (0.64 cm2) to get units in X cm2.
The heterogeneous and complex nature of skin membranes
result in deviations from ideal properties, which is consistent with
several impedance studies on skin [14,40,41,43]. This issue is
accounted for by the empirical CPE element, which can be used
to derive an effective capacitance Ceff of the SC [44]. For this, we
followed a procedure in which the SC layers are considered to have
a distribution of varying time-constants in the vertical direction
across the skin membrane [40]. The effective capacitance Ceff was
derived from the high frequency region from the imaginary impe-
dance data following a graphical representation method, which
does not involve any fitting [44]. The procedure used to calculate
Ceff from the impedance spectroscopy data is described in detail
in the supplementary text with examples of raw data
(cf. Figs. S5–S9). In addition, all impedance data from the initial
and final measurements are compiled in Table S2.3. Results
We employ solid-state NMR methods that enable detailed
characterization of the effect of TC and DexP on the SC molecularcomponents under varying hydration conditions. The effect of the
same excipient compounds on the skin barrier function is investi-
gated at similar hydration conditions. In addition, we performed
impedance measurements before and after the steady-state diffu-
sion experiments to investigate the effect of TC and DexP on the
electrical resistance and capacitance of the skin membrane.
3.1. Molecular mobility in SC components as revealed from PT ssNMR
PT ssNMR [30,31] was recently successfully employed on intact
SC to characterize molecular dynamics in individual segments of
SC lipid and protein components [13,14,18]. The experiments are
based on natural-abundance 13C solid-state NMR and involves
MAS (magic angle spinning) and heteronuclear decoupling to min-
imize peak broadening from CSA (chemical shift anisotropy) and
heteronuclear scalar and dipolar couplings to obtain chemical shift
resolution of 13C molecular segments. Information on the molecu-
lar dynamics is obtained by comparing the signal intensities from
the INEPT (insensitive nuclei enhanced by polarization transfer)
and CP (cross polarization) pulse sequences, relative to the signal
obtained in the DP (direct polarization) experiment. INEPT is nor-
mally used to enhance the signal in liquid state NMR [29], while
CP is a corresponding standard scheme employed in solid-state
NMR [28]. The DP experiment does not involve polarization trans-
fer and the DP signal intensity may thus be used as a reference in
comparison to the INEPT and CP signal intensities. The INEPT and
CP signals from a specific resolved segment will depend on its
dynamical properties, which may be defined in terms of mobility
or rigidity. The distinction between rigid and mobile molecular
segments is rationalized by the relation between the experimental
DP, INEPT, and CP signal intensities with respect to the theoretical
signal intensity ratios, as described in detail by Topgaard et al. [30].
In brief, the INEPT and CP signal intensities vary as a function of the
rotational correlation time (sc) and the 13C–1H bond order param-
eter SCH, from which it is possible to distinguish different dynamic
regimes [30]. The correlation time sc measures the rate of the
13C–1H bond reorientations, while the order parameter SCH quanti-
fies the time-averaged orientation of the 13C–1H bond with respect
to a main symmetry axis (for example the normal axis of a lipid
bilayer) and is thus a measure of anisotropy. Both the INEPT and
the CP pulse sequences transfer magnetization from 1H nuclei to
neighboring 13C and enhance the resonance signals depending on
the dynamical properties of the molecular segments. The polariza-
tion transfer occurs in different ways, and this is taken advantage
of in PT ssNMR for selective signal enhancement of mobile or rigid
molecular segments. For INEPT, the transfer of magnetization
occurs via through-bond scalar couplings that act in favor for signal
enhancement of mobile segments with isotropic motion. For CP the
transfer of polarization occurs via through-space dipolar interac-
tions, which is fast for rigid segments with anisotropic reorienta-
tions leading to efficient signal enhancement in these cases.
A detailed peak assignment of most 13C resonances of intact SC
was previously obtained by comparing spectra from extracted SC
protein and lipid components and model lipids [13]. Based on this
peak assignment we investigated the effect of TC and DexP on the
mobility (fluidity) of SC molecular components by PT ssNMR. Rep-
resentative data, obtained from sheets of isolated SC that were
soaked in either solutions of PBS with added TC or DexP (0, 5 or
30 wt%), are shown in Fig. 2. The complex composition of SC is
reflected in the crowded 13C NMR spectra, which show overlaid
DP (grey), CP (blue), and INEPT (red) spectra from the SC samples.
Relevant ‘‘signature peaks” from the protein and lipid components
for intact SC are labeled in Fig. 2A. The Gly Ca (44 ppm), Ser Ca
(57 ppm), and Ser Cb (62 ppm) peaks are most relevant for char-
acterizing the mobility of the keratin filaments due to their gener-
ally high abundance in keratin (approximately 40% of the total
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Fig. 2. PT ssNMR 13C spectra (DP in grey, CP in blue, INEPT in red) from SC sheets treated for 8 h in neat PBS or formulations containing either 5 or 30 wt% transcutol (TC) or
dexpanthenol (DexP). Resonances from prominent protein and lipid molecular components are labeled in spectra (A), corresponding to SC in neat PBS. (B) shows spectra from
SC sheets equilibrated at 93%RH after being soaked in neat PBS for 8 h. The peaks from TC are labeled according to Fig. 1 in spectra (C) and (E), while the resonances from DexP
are labeled in (D) and (F). In all cases, sample treatment and NMR experiment were performed at 32 C. The signal intensity is equal in all spectra. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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[13]. In particular, the N- and C-terminal domains of the keratin
filaments are highly enriched in glycine and serine [13]. The lipid
carbons represent a minor fraction of the total number of carbons
in SC. However, most of the SC lipids are saturated and have long
hydrocarbon chains in the range of C14–C32 [45,46]. The majority
of these carbons resonates at similar chemical shifts, which com-
pensate for the fact that the lipid carbons represent a minor frac-
tion. The methylene groups (CH2)n with all-trans (AT)
conformation resonate at 33 ppm, while methylene groups
exhibiting a distribution of trans/gauche (TG) conformers resonate
at 31 ppm [47]. In addition to the main methylene carbon peaks,
the terminal carbons of the lipid chains, xCH3 (15 ppm) and
(x  1)CH2 (23 ppm), can be used as markers for the SC lipids.
Both TC and DexP can be distinguished in the NMR spectra in
Fig. 2, and the assignments of the carbon resonances from these
molecules are indicated. The signal intensity from the excipient
molecules increases with their concentration in the solution used
to equilibrate the SC samples. The DP signal is fairly quantitative
in the dynamical regimes where INEPT gives signal [30], which is
here the case. It is therefore possible to estimate the relative
amounts of TC and DexP molecules in SC from the signal intensity
in the NMR spectra. By comparing the DP signal intensity of the
carbon resonances from the excipient molecules in Fig. 2, we esti-
mate that the sample treated in 30 wt% TC contains 5.5 ± 0.3 times
more TC as compared to the sample treated in 5 wt%. The corre-
sponding number for the samples treated in DexP is 6.5 ± 2.2.These estimations indicate that the partitioning of the excipient
molecules into the SC samples is close to proportional to their con-
centration in the PBS formulation. It is further noted that the reso-
nances from the excipient molecules are characterized with
prominent INEPT signal and no CP contribution, implying that
these excipient molecules are present in the SC samples in a mobile
state.
In all spectra in Fig. 2, the CP signal from rigid SC molecular seg-
ments is dominating (excluding the INEPT contribution from the
excipient carbons). The high CP signal intensity indicates that the
main fraction of the SC components is in a rigid state. The most
prominent lipid CP peak is found for the all-trans (CH2)n reso-
nances at 33 ppm, while the broad CP peak centered at 57 ppm is
mainly ascribed to Ca resonances of the peptide bond from all
amino acid residues (except Gly Ca). For most of the spectra in
Fig. 2, several resonances are also characterized with distinct INEPT
signal, which implies that a small fraction of the SC protein and
lipid components is mobile under these conditions.
The general conclusion from the data in Fig. 2 is that the overall
behavior of SC lipid and proteins is similar for the SC samples trea-
ted in solutions of pure PBS or solutions with TC or DexP. It was
previously shown that the molecular dynamics in SC components
strongly depend on its hydration [13,48,49], which can be
expressed in terms of thermodynamic water activity (ranging
between zero and unity). When the SC sample is equilibrated in
an excess aqueous solution with given solute composition, or with
vapor with given RH, the water activity in the SC sample will reach
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solution/vapor phase (see Ref. [14] for example). To take the effect
of hydration into account when evaluating the present data, we
measured the water activity in all formulations used (Table S1,
Fig. S2), and relevant values are indicated in Fig. 2. The water activ-
ity is clearly reduced with increasing concentration of the excipi-
ents. To enable comparisons of the effect of the excipients at
similar water activities, we included also data for a SC sample that
was first soaked in the PBS solution and thereafter equilibrated at
93%RH (Fig. 2B). The latter set of data differs from all other spectra
in Fig. 2 in that it shows no strong INEPT signals for any lipid or
protein segment (Fig. 2B). It is a striking observation that the SC
samples treated with TC or DexP show similar behavior as the fully
hydrated SC sample (Fig. 2A) even though the water activity is
reduced by the addition of excipients. From a more detailed anal-
ysis of the spectra in Fig. 2, small variations in the INEPT enhance-
ment due to the treatment of different formulations can be
detected, and this will be analyzed below.61 61 61 61 61
δ / ppm
*C5  *C5  .
5656565656
δ / ppm
Fig. 4. PT ssNMR 13C spectra (DP in grey, CP in blue, INEPT in red) in close-up
showing resonances from (A) lipid chain methylene groups (CH2)n and (B and C)
ceramide headgroup segments. The signal is 3 times more intense in A and 1.3
times more intense in B and C, as compared to the intensity in Fig. 2. *C7 and *C5 in
(A) and (B), respectively, indicate carbon resonances from the excipient molecules
(cf. Fig. 1). (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)3.2. The effect of TC and DexP on molecular dynamics in SC lipid
components
Fig. 3A and B show carbon resonances corresponding to relevant
lipid and cholesterol molecular segments to enable a detailed com-
parison between the spectra from SC samples treated with neat
PBS or different formulations containing either TC or DexP. We first
focus on the chemical shift from the methylene groups in the lipid
chains (Fig. 4A), where the DP spectrum displays one peak centered
around 33 ppm for rigid acyl chains with all-trans conformation,
and one smaller peak centered around 31 ppm for more disordered
acyl chains with a distribution of trans/gauche conformers [47].
Furthermore, it is seen that the peak around 33 ppm is selectively
more enhanced in the CP spectrum, while the peak around 31 is
more enhanced in the INEPT spectrum, showing that a small frac-
tion of methylene carbons undergoes fast reorientation between
the conformations. The presence of TC and DexP in the SC results
in more intense INEPT signal (relative to DP) from trans-gauche
(TG) resonances in comparison to the SC that was treated in neat
PBS, implying slightly higher mobility in the SC lipids. This effect
is most pronounced in the SC sample treated with the solution con-
taining 5 wt% DexP. Still, it should be pointed out that the promi-
nent CP peak from the all-trans configured acyl chains is similar
for all samples, which implies that the main fraction of lipids
remain in a rigid all-trans configuration in all conditions
investigated.
From a detailed investigation of the spectra in Fig. 2 several
prominent INEPT peaks were identified and assigned to resonances
from ceramide and cholesterol carbons [13,50]. For clarity, we
present close-ups of the peaks corresponding to these carbons,HO
O
NH
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C9
(B) Cholesterol
Cer C1
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(CH2)
Fig. 3. Relevant lipid and protein molecular segments, here exemplified with (A) cstarting with ceramide resonances in Fig. 4B and C. Interestingly,
the INEPT peaks from ceramide headgroup carbons [13,18] are
more pronounced (relative to DP) in the spectra corresponding to
the SC samples treated with TC or DexP, as compared to SC treated
in neat PBS buffer. It is here noted that the peak corresponding to
TC C5 (Fig. 4B) overlaps with the signal from the CER C2 resonance,
which makes it impossible to draw any conclusions on how TC
influences the mobility of this particular carbon segment. How-
ever, the presence of DexP clearly increases the INEPT signal from
the CER C2 resonance in comparison to the spectra from the SC
sample treated in PBS solution. This indicates that DexP increases
the mobility of the ceramide C2 headgroup segment. In the close-
up of the spectra from the CER C1 resonance, the INEPT signal is
of moderate intensity for the spectra corresponding to the TCSer Cβ
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compared to the SC sample without the added excipients. It should
be pointed out that the CER C1 resonance occurs in the chemical
shift regime where several amino acid residues are expected to
give signal from the Ca of the peptide bond. Therefore, it is difficult
to uniquely determine if the observed effects is only due to
enhanced mobility in the CER C1, where the differences in cera-
mide headgroups (e.g. CER NS or NP) give rise to minor changes
of the resonance frequency, or from enhanced mobility in both
CER C1 and protein resonances from the peptide bond Ca.
Similar effect of enhanced mobility as seen for the ceramide
headgroups is also seen for cholesterol. From Fig. 5 it is clear that
the INEPT intensity from several cholesterol carbons is enhanced
when either TC or DexP is present in the SC sample. The most
prominent effect is observed in the spectra corresponding to the
SC sample treated with the solution containing 5 wt% DexP.
3.3. The effect of TC and DexP on molecular dynamics in SC protein
components
The spectra corresponding to the SC sample treated in neat PBS
solution (Fig. 2) show clear INEPT peaks from the Gly Ca, Ser Ca,
and Ser Cb resonances; see Fig. 3C for the chemical structure of
these molecular segments.
To enable more detailed comparisons, we present close-ups of
the relevant chemical shifts in Fig. 6. It is shown that Gly Ca, Ser
Ca, and Ser Cb resonances give rise to prominent INEPT signal in
all spectra. This is consistent with increased mobility of the flexible
N- and C-terminal domains of the individual protein chains in the
keratin filaments. In general, these segments do not provide any CP52525258 58 58 58 58
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Fig. 5. PT ssNMR 13C spectra (DP in grey, CP in blue, INEPT in red) in close-up showing res
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Fig. 6. PT ssNMR 13C spectra (DP in grey, CP in blue, INEPT in red) in close-up showing res
as compared to the intensity in Fig. 2. *C5 in (A) indicate a resonance from TC (cf. Fig. 1
referred to the web version of this article.)signal with similar line shape as the DP or INEPT peaks, which
implies that these molecular segments are in the fast dynamic
regime with isotropic reorientations. A more detailed comparison
shows that the relation between the INEPT and DP signals in the
spectra corresponding to the SC samples treated in neat PBS,
30 wt% TC, and 30 wt% DexP is very similar. In addition, the spectra
corresponding to the SC samples treated in 5 wt% TC or DexP show
a higher INEPT signal, relative to the DP signal. These findings sug-
gest that the mobility of the keratin filament terminals is slightly
increased in the case of SC treatment with 5 wt% of TC or DexP,
as compared to treatment in solutions of neat PBS or PBS with
30 wt% of the excipients.
3.4. Steady-state flux of the model drug
The molecular information obtained with the solid-state NMR
method can be related to the macroscopic effects of the same
excipients on the SC barrier properties under similar hydration
conditions. We investigated permeation of the model drug Mz
across skin membranes in contact with solutions of the same com-
position as used in the NMR studies. The composition of the formu-
lation can drastically influence the activity (chemical potential) of
the drug molecule in the formulation, which in turn affects the
release rate and the driving force for transport (the activity gradi-
ent across the membrane). To accomplish well-defined experimen-
tal conditions we adjusted the Mz activity to achieve similar
thermodynamic activity of the drug in all formulations according
to its solubility in the different solutions (see Fig. S1).
The mean values of the measured steady-state fluxes of Mz and
TC across skin membranes are compiled in Table 1. The overall43434343435252
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Table 1
Steady-state flux (Jss/lg cm2 h1) of Mz, TC, and DexP across skin membranes (example of data are shown in Fig. S3). Deviations are given by the standard error of the mean
(±SEM). LOD is limit of detection. The measured water activity (aw) in the formulations is also given.
Formulationa Jss (skin) aw
Mz TC DexP
PBS 6.1 ± 0.9 (n = 12) n.a. n.a. 0.992 ± 0.002 (n = 2)
TC5 6.3 ± 1.3 (n = 10) 55 ± 11 (n = 7) n.a. 0.984 ± 0.002 (n = 2)
TC30 6.7 ± 1.0 (n = 12) 231 ± 40 (n = 7) n.a. 0.936 ± 0.000 (n = 2)
DexP5 6.9 ± 1.3 (n = 10) n.a. n.a. 0.986 ± 0.001 (n = 2)
DexP30 4.5 ± 1.0 (n = 10) n.a. <LOD (n = 7) 0.955 ± 0.001 (n = 2)
a Abbreviations: TC - transcutol, DexP - dexpanthenol. Numbers give concentration in wt%.
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similar for all formulations. The only exception is found for the for-
mulation that contains 30 wt% DexP, which gives slightly lower Mz
flux. However, one-way ANOVA-analysis did not reveal any statis-
tical difference between this formulation and the others (p-level
0.60). From Table 1, it is further concluded that the flux of TC
increases with increasing concentration gradient (i.e., concentra-
tion in the donor solution), and the average value of the steady-
state flux of TC is 4 times higher from the 30 wt% formulation,
as compared to the formulation with 5 wt%. The corresponding
comparison between the total cumulative mass of permeated TC
is 6 times higher from the formulations with high concentration.
With respect to the standard deviations for the flux it is thus rea-
sonable to say that the TC flux is close to proportional to the TC con-
centration in the donor formulation. We finally note that the Mz
flux does not vary significantly between the formulations with 5
or 30 wt% TC even though the formulations have different water
activity and SC likely contain different amounts of TC in these cases.
The corresponding analysis for permeation of DexP was not possi-
ble as the concentration in the receptor cell was below the limit
of detection (LOD  100 lg mL1) even for the formulation with
the highest concentration of DexP. It should here be noted that
the method used for DexP analysis is less sensitive as compared
to that used for TC analysis, and that a receptor concentration of
DexP that is equal to LOD would correspond to a flux of approxi-
mately 240 lg cm2 h1, which is similar to the measured TC flux.
3.5. The effect of TC and DexP on skin permeability at reduced water
activity
In the diffusion cell experiments, the water activity of the
receptor solution is kept constant at physiological conditions
(aw  0.992), while the water activity of the donor solutions isa
w
A B
Fig. 7. (A) Normalized steady-state flux of Mz and (B) relative change of Ceff as a functi
relative change in flux compared to the Mz flux from donor solution of neat PBS, while dat
standard error of the mean (±SEM). *Polymers show data from Ref. [11] and *PEG showslower than 0.992 and depends on the concentration of TC or DexP
(Table 1). The experimental set-up mimics in vivo conditions,
where the water activity inside the body is constant at physiolog-
ical conditions, while the outside atmosphere, a film of formula-
tion, etc., can vary between dry and humid. In Fig. 7A, the
experimental data are presented as the average Mz flux as a func-
tion of water activity in the donor cell. The results are compared to
previously published data of Mz flux across skin in conditions
where the water activity in the donor cell was regulated by the
addition of various amounts of large water soluble polymers [11].
In the latter case, the polymers do not partition into the skin mem-
brane [51,52], and only act to reduce the water activity, in ana-
logue to so-called osmotic stress technique [53]. The main
conclusion from Fig. 7A is that the steady-state Mz flux remains
high at dehydrating conditions when the water activity is adjusted
by the addition of TC or DexP, while there is a clear reduction in Mz
flux when the water activity is adjusted by the addition of water-
soluble polymers. This difference can be explained by the parti-
tioning of the smaller molecules (TC or DexP) into the skin mem-
brane where they influence its properties, while the relatively
large polymers do not partition inside the membrane and thus only
act to dehydrate the skin [51,52].
3.6. The effect of TC and DexP on the skin electrical properties
The studies of Mz permeation across skin were complemented
with impedance measurements using the very same samples and
conditions in terms of formulation composition. Experiments were
performed prior and after the diffusion cell studies, and the data
are summarized in Table 2. To minimize the contribution from
the biological variability between different skin membranes, which
is generally observed [14,37–39], we present the impedance
results as the relative changes of R and Ceff by calculating the ratio0.82 0.84 0.86 0.88 0.9 0.92 0.94 0.96 0.98 1
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on of water activity (aw) in the donor formulation. Data in (A) are presented as the
a in (B) show the ratio of the final and initial value of Ceff. Deviations are given by the
data from Ref. [14].
Table 2
Relative change of R, Ceff for skin membranes after 24 h exposure to the model drug
formulations. The relative change is given by the mean value of the ratios between the
final (f) and initial (i) values for each individual skin membrane (see Tables S2–S3 for
the complete set of individual data). Deviations are given by the standard error of the
mean (±SEM).
Formulationa CR ¼ RfRi CCeff ¼
Ceff ;f
Ceff ;i
PBS (n = 10) 0.13 ± 0.02 2.1 ± 0.1
TC5 (n = 5) 0.20 ± 0.06 1.6 ± 0.2
TC30 (n = 5) 0.22 ± 0.05 1.4 ± 0.2
DexP5 (n = 5) 0.15 ± 0.03 1.8 ± 0.1
DexP30 (n = 4) 0.70 ± 0.15 1.4 ± 0.1
a Abbreviations: TC - transcutol, DexP - dexpanthenol. Numbers give concen-
tration in wt%.
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(see Tables S2–S3 for the complete set of individual data). The
overall conclusion is that R decreases during the diffusion experi-
ments, while Ceff increases. For simplicity we denote the ratio
between the final (f) and initial (i) values as Cx ¼ xfxi , where x is
either R or Ceff. A more detailed comparison of the impedance data
for the different formulations shows that there is no statistical
difference between CR corresponding to donor solutions of PBS,
TC5, TC30, and DexP5 (p-level 0.28), while there is a significantly
lower decrease in CR for the case corresponding to DexP30
(p-level 0.00). Furthermore, the increase of CCeff is more pro-
nounced for neat PBS and for the formulations with 5 wt% TC or
DexP, as compared to the formulations containing 30 wt% TC or
DexP.
The change of CCeff for the skin membranes treated with the dif-
ferent formulations are presented in Fig. 7B. The data are presented
with respect to the variation in water activity in the donor solution.
Strikingly, the results show a clear trend of stronger increase of Ceff
for skin membranes exposed to formulations with high water
activity. The results in Fig. 7B are compared to results from a pre-
viously reported impedance study on skin membranes where the
water activity in the donor cell was regulated by the addition of
water soluble polymers [14]. The reference data [14] show that Ceff
of the skin membranes exposed to a formulation with relatively
low water activity (i.e. aw = 0.826, 65 wt% PEG 1500 Da) decreases
slightly over the 24 h exposure time, which is in strong contrast to
the present results. Taken together, the results is consistent with
that Ceff is highly dependent on the SC hydration, which is con-
trolled by the external water activity in the formulation [14]. The
corresponding changes of CR are presented in Fig. S10. In conclu-
sion, the results show that both CCeff and CR strongly depend on
the water activity.4. Discussion
4.1. Relating SC molecular and macroscopic properties
It is clear that changes of the structure and molecular dynamics
of the SC protein and lipid components can have large impact on
the macroscopic properties of the SC membrane, including its bar-
rier properties, electrical resistance and capacitance characteris-
tics, as well as material properties like strength and elasticity.
Here, we aim to relate the observed effects of TC and DexP on SC
barrier properties to the molecular effects induced by these excip-
ients on the mobility of SC lipids and protein components. This aim
was achieved by investigating the macroscopic barrier properties
from steady-state flux and impedance measurements and relating
these results to the molecular properties measured by solid-state
NMR methods. The experiments were designed so that the skinsamples were treated with the same formulations under well-
defined conditions in terms of water activity, thus enabling direct
comparison of the results from the different experimental
methods.
The first conclusion from the combined data presented here is
that TC and DexP have no major effect on the SC permeability of
Mz, as compared to the reference sample of (close to) fully
hydrated SC treated in neat PBS buffer. However, this comparison
neglects the fact that the different formulations do not have the
same water activity. Previous studies have shown large changes
in SC barrier function, SC electrical properties and molecular
mobility in SC lipid and proteins for the corresponding range of
water activities [6,11,13,14,48,49]. In the present study, the skin
samples were treated in solutions with different amounts of excip-
ients and at different water activities. In the analysis we need to
consider the combined effects of SC dehydration and interactions
between SC components and the added excipient molecules. In
the comparison in Fig. 2 we therefore include the reference data
for the neat SC at similar water activities as in the formulations
(Figs. 2 and 7 and S10). The clear conclusion from this comparison
is that both TC and DexP maintain the properties of hydrated SC
also in slightly dehydrated conditions. The steady-state flux results
can be understood on basis of the observations from the PT ssNMR
experiments showing that the lipid chain carbons have similar
mobility in all samples, independent on hydration degree
(Fig. 4A). The same conclusion was previously drawn for skin
membranes treated other small polar molecules, urea or glycerol,
resulting in a retained and high skin permeability at dehydrating
conditions [17]. Furthermore, detailed studies of the molecular
mobility of SC lipid components and other lipid systems have
shown that samples that contain urea or glycerol retain mobility
similar to fully hydrated samples also in dehydrated conditions
[18,54,55]. TC and DexP have similar physicochemical properties
as urea, glycerol, and other NMF substances, and we propose that
the same mechanism of retained molecular mobility of SC at dehy-
drating conditions act also for DexP and TC at corresponding
situations.
A more detailed inspection of the NMR data reveals small vari-
ations in the molecular mobility of some protein and lipid seg-
ments (Figs. 4–6), which are more difficult to directly relate to
the observed unchanged SC permeability to the model drug Mz.
This might in part be explained by that the measurement precision
in the diffusion cell studies is limited due to biological variations
between skin samples. In principle, one can expect that increased
fluidity in SC molecular components will lead to increased SC effec-
tive permeability. However, a deeper analysis of this connection
between molecular properties and barrier function requires also
information on arrangement of the mobile and rigid SC compo-
nents in relation to the possible transport routes through skin. Typ-
ically, one expect that fluidizing the lipid hydrocarbon layers can
provide additional routes for transport, or increase the size of
existing ones, allowing for enhanced molecular transport across
the layer. On the other hand, increased mobility in the plane of
the polar headgroups of the bilayer likely has less impact on the
overall permeability, as the main resistance to the flux lies in the
rigid hydrocarbon chains of the lipid lamellae (cf. (CH2)n in
Fig. 4A). This is highly relevant with respect to the present findings
where the treatment with both TC and DexP caused increased
mobility of the ceramide headgroup segments located at the inter-
face of the bilayer (Fig. 4B and C) without leading to increased per-
meability of Mz across SC (Fig. 7A) due to similar mobility of the
lipid chain carbons in all samples (Fig. 4A).
To explain the impedance results we can start by concluding
that the SC samples treated in solutions with TC or DexP indeed
have different solvent composition within the membrane as com-
pared to the neat PBS buffer as the excipient molecules partitions
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ence of these excipient molecules is proportional to the concentra-
tion of the formulation in contact with the SC membrane. In other
words, even though the molecular mobility is similar in the differ-
ent SC samples, it is reasonable that the electrical properties differ
as the solvent composition inside the SC change. The dielectric
properties of the capacitive domains are expected to change with
the addition of the excipients, leading to a less pronounced
increase of the effective membrane capacitance (assuming that
the dielectric constant e (water) > e (TC/DexP)) (Fig. 7B). This
would be consistent with a preferential location of the excipient
molecules in the interfacial headgroup regions of the extracellular
lipid lamellae, where the capacitive domains are expected to be
located [41,56–58]. From the NMR data we only observe the
molecular consequences of adding certain molecules, and not their
exact position in the SC matrix. Still, the observations of increased
mobility in the ceramide headgroups (Fig. 4B and C) imply that the
added excipient molecules have strong influence in this layer. This
is also consistent with the log P values of 0.42 and 0.99 for TC
and DexP, respectively, implying preferential partitioning in more
polar environments, such as the headgroup region of the lipid
lamellae.4.2. Molecular consequence of adding TC or DexP to intact SC
SC is a composite where the major fraction is composed of cor-
neocytes (85 wt% in dry SC) [15]. The multilamellar lipid matrix, on
the other hand, contains long hydrophobic lipids with very low
water content [59]. When foreign compounds are added to SC, they
partition between these regions on basis of their solubility in the
different compartments. From the NMR experiments, we are able
to distinguish between the molecular consequences of adding the
excipients TC and DexP on the SC lipid and protein components.
The results in Figs. 4 and 5 show that the addition of TC and
DexP to intact SC leads to an increase of the fluidity in several lipid
and cholesterol segments, as compared to the neat SC that was
treated in neat PBS solution. Likewise, Figs. 2 and 6 show that
treatment of SC in neat PBS or in TC and DexP formulations leads
to enhanced mobility of the glycine and serine residues, which
are highly abundant in the terminal domains of the keratin fila-
ments, as compared to the SC sample equilibrated in 93%RH that
is associated with rigid protein segments. It was previously
demonstrated using the same PT ssNMR method on intact SC thatKeratin filaments 
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aw=0.955 Mobile 
Rigid 
Fatty acids Ceramides Cholesterol 
Fig. 8. Schematic interpretation of the molecular mobility of the SC protein (keratin filam
rigid molecular segments, while red represents mobile molecular segments. Grey indi
interpretation of the references to colour in this figure legend, the reader is referred tothe mobility of the terminal domains of the keratin filaments
strongly decreases under dehydrating conditions [13,14]
(Fig. 2B). This is in strong contrast to the present results
(Figs. 2C–F and 6), which show that the addition of TC or DexP
leads to high mobility in the terminal protein segments also in
slightly dehydrated conditions.
For clarity, we summarize our interpretation of the NMR results
in Fig. 8. The overall effect is fairly similar for both excipients and
both concentrations investigated. When the SC is exposed to for-
mulations with low water activity it experience dehydration,
which in general leads to increased rigidity of the SC lipids and
proteins [13,14]. The present results show that TC and DexP act
to retain, or increase, the mobility of several SC lipid and protein
segments in dehydrated conditions. This indicates that these excip-
ient molecules interact with lipid segments of the extracellular
lamellae and protein residues in the corneocytes in SC and thus
compensate for reduced hydration by retaining/increasing molecu-
lar fluidity.
4.3. The influence of TC or DexP on skin membrane resistance
The parameter R reflects the restriction of ion transport across
the total SC, which includes both the isolated corneocytes and
the continuous extracellular lipid lamellar structures. In this study
we evaluate the skin membrane resistance in terms of the relative
change CR ¼ RfRi (see Table 2 and Fig. S10A). This ratio reveals how
the formulations in contact with the skin membrane influences
the membrane resistance relative to its initial value obtained
before the treatment with the formulation. A first conclusion is
that CR decreases for all skin membranes, implying that all aque-
ous formulations investigated affect the skin membranes by
decreasing the restriction of ion transport across the barrier. This
is likely explained by increased hydration during the prolonged
diffusion cell experiments, as compared to the initial hydration
state of the membrane. When the skin membrane is exposed to a
formulation with low water activity (aw = 0.826) the membrane
resistance increases leading to a significantly higher value of CR
(see Fig. S10A). These changes of ion restriction should predomi-
nantly be related to hydration/dehydration induced lipid mobility
in the extracellular continuous lamellae, while changes of mobility
of the intracellular protein components upon hydration/dehydra-
tion only can influence the mobility of intracellular ions. Thus,
the observed effect on R is in all cases dependent on the ability+ 5 wt% Transcutol (  ) 
aw=0.984 
PBS 
aw=0.992 
ased water activity aw) 
+ 5 wt% Dexpanthenol (  ) 
aw=0.986 
ents) and lipid components (fatty acids, ceramides, and cholesterol). Blue represents
cates the unknown mobility in the headgroup of fatty acids and cholesterol. (For
the web version of this article.)
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resents the main barrier [1], and this ability may be increased due
to formation of more fluid regions in the bilayers (Figs. 4 and 5)
where ions can diffuse with less restriction.
4.4. The influence of TC or DexP on skin membrane capacitance
The impedance data show the strongest increase in Ceff for skin
membranes in contact with the formulations having the highest
water activities (see Fig. 7B). The SC capacitance has mainly been
attributed to the dielectric nature of lipid structures that impede
transport of ions in the SC membrane [41,56–58]. If Ceff is ascribed
completely to the SC lipid lamellae then these domains can be
visualized as dielectric medium in between the corneocytes. In this
case, the capacitance (F cm2) depends on the thickness, d, and the
dielectric constant, e, of these domains, according to Eq. (1), where
e0 is the permittivity of vacuum (8.9  1014 F cm1).
Ceff ¼ e0ed ð1Þ
The thickness d of the lipid lamellae has been demonstrated to be
unaffected by hydration from X-ray diffraction studies on pig SC
[14,60]. Thus, as a first approximation, an increase or decrease of
CCeff can be explained by that the dielectric properties of the capac-
itive regions of SC change due to addition or removal of water mole-
cules, respectively. This effect is clearly illustrated by the reference
data in Fig. 7B (obtained with 65 wt% PEG 1500 Da), where the low
water activity (aw = 0.826) leads to a slight decrease of CCeff due to
dehydration [14]. The fact that CCeff is lower for the formulations
containing higher amounts of excipients (i.e. lower water activities)
in the donor formulation (Fig. 7B) can thus be explained by dehy-
dration of the capacitive regions of SC. However, it is also likely that
incorporation of TC or DexP into the capacitive regions results in
lower values of e, based on the assumption that both TC and DexP
have lower dielectric constants as compared to water. Taken
together, it is likely that both these effects work in parallel leading
to a clear reduction of CCeff at lower water activities (Fig. 7B).
4.5. Implications to skin formulations
Studies like this can be used to increase the understanding of
the impact of excipients on molecular properties of the skin to
design and justify the choice and composition of excipients in a
pharmaceutical formulation. When developing a formulation the
thermodynamic activity of all components (including water) is
important for the performance of the final product. Normally, the
water activity in the viable epidermis is controlled at physiological
conditions, while the water activity of the external environment is
determined by the relative humidity in air (RH). When the SC is not
exposed to any formulation, its hydration is thus determined by
boundary conditions set by the underlying tissue and the sur-
rounding vapor. However, when a formulation is applied onto
the skin surface, the water activity in the outer surface of the skin
is instead determined by the properties of the (drying) film of the
formulation [61]. This change in boundary condition might indeed
affect the properties of the skin barrier; for example, increased flu-
idity of the SC molecular components likely leads to increased SC
effective permeability also at ambient hydration conditions. This
reasoning highlights the importance of defining and controlling
the water activity in topical formulations to maximize the benefi-
cial effects of excipients and active ingredients with respect to dis-
eased or dry skin.
It is shown here that TC and DexP can be used to control the
skin permeability in relation to the external water activity. Extrap-
olated to a real situation, the results demonstrate how these excip-ients may be used to generate the properties of a hydrated skin
membrane also in dehydrated conditions. Water has a relatively
high vapor pressure compared to most excipients in formulations.
Therefore, these polar excipient molecules will be less affected by
evaporation and stay on the skin application site in situations
where water evaporates.
Another mechanism that may alter the skin permeation for for-
eign molecules is the excipient impact on the solubility in the skin
matrix. The NMR experiments showed both TC and DexP to be in
liquid state in the SC mixture, which suggests that they can alter
the solubility of other components in the skin, and thereby affect
the permeation. The impact of improved solubility in hydrated skin
is most likely less pronounced for small hydrophilic molecules,
such as Mz, as compared to small hydrophobic substances
(in hydrated SC). In fact, TC has been suggested to increase the skin
solubility of more lipophilic substances both in vitro and in vivo
[62–64]. The present study provides completely new data showing
that TC and DexP increase the molecular mobility of several lipid
segments, which is likely the reason for increased skin solubility
of more lipophilic substances [62–64].5. Conclusions
In this work we investigate the effect of TC and DexP on the
molecular mobility of SC components and on the macroscopic
membrane properties, such as permeability and electrical charac-
teristics. The use of complementary methods provides a novel tool
to link molecular properties with macroscopic effects, and the
results lead to deepened understanding of how these excipients
influence lipid and protein components of the complex stratum
cornuem barrier membrane. We envisage that the experimental
approach employed in this study is highly useful for future rational
development of formulations for topical or transdermal drug deliv-
ery. The significance of the present results is highlighted in the fol-
lowing main conclusions:
(i) Addition of TC or DexP leads to increased mobility of SC
molecular components (i.e., both lipids and proteins) even
though their presence acts to lower the water activity and
thus impose dehydrating conditions.
(ii) TC and DexP can be used to retain the high skin permeability
of a hydrated membrane at reduced hydration conditions,
which otherwise would lead to reduced flux due to dehydra-
tion induced molecular rigidity of the SC barrier compo-
nents. This finding is explained by retained molecular
mobility of SC at dehydrating conditions in the presence of
TC and DexP.
(iii) The presence of TC and DexP leads to increased mobility in
the ceramide headgroups, which suggests that TC and DexP
disturb the packing in the interfacial headgroup layer of lipid
layers. Strikingly, the impedance results show a clear trend
of stronger increase of Ceff for skin membranes exposed to
formulations comprising TC and DexP and/or high water
activity. This is consistent with a preferential location of
the excipient molecules at the interfacial regions of the
extracellular lipid lamellae, where the capacitive domains
are expected to be located.
(iv) TC has previously been suggested to increase the solubility of
lipophilic substances in the skin [62–64]. The new observa-
tion of increasedmobility of several lipidmolecular segments
after exposure to TC (and DexP) provides a likely explanation
of increased skin solubility of lipophilic substances.
(v) Urea and glycerol have clear effect on the mobility of SC lipid
and protein components in dehydrated conditions [18],
which can be related to increasing pliability and softness
S. Björklund et al. / Journal of Colloid and Interface Science 479 (2016) 207–220 219of SC treated with these compounds under dry conditions
[20]. TC and DexP have similar physicochemical properties
as urea, glycerol, and other NMF substances, and we hypoth-
esize that also these molecules influence the molecular
dynamics of the SC in a similar manner.
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